Florida Senate - 2014 COMMITTEE AMENDMENT
Bill No. SB 742
Ì876268SÎ876268
LEGISLATIVE ACTION
Senate . House
Comm: WD .
04/09/2014 .
.
.
.
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
1 Senate Substitute for Amendment (646294) (with directory
2 and title amendments)
3
4 Between lines 50 and 51
5 insert:
6 (7)(a) In order to protect the safety and welfare of racing
7 animals and the integrity of the races in which they
8 participate, the division shall adopt rules establishing the
9 conditions of use and maximum concentrations of drugs,
10 medications, and naturally occurring substances identified in
11 the most recent Controlled Therapeutic Medication Schedule
12 adopted by the Association of Racing Commissioners
13 International, Inc., (ARCI) on or before April 30, 2014.
14 Controlled therapeutic medications may include only the specific
15 medications and concentrations allowed in biological samples
16 that have been approved by ARCI as controlled therapeutic
17 medications. The division shall adopt laboratory-screening
18 limits approved by ARCI for drugs and medications that are not
19 included as controlled therapeutic medications.
20 (b) The division rules must designate the appropriate
21 biological specimens by which the administration of medications,
22 drugs, and naturally occurring substances are monitored and the
23 testing methodologies for screening and confirmation.
24 (c) The division rules must include a classification system
25 for medications and drugs and a corresponding penalty schedule
26 for violations, which must incorporate the Uniform
27 Classification Guidelines for Foreign Substances, revised
28 December 2013, as promulgated by ARCI. The rules must specify
29 those drugs that are considered prohibited substances, whose
30 presence in a sample in prescribed concentrations may result in
31 summary suspension pursuant to paragraph (3)(b).
32 (d) The rules must include conditions for the use of
33 furosemide to treat exercise-induced pulmonary hemorrhage.
34 (e) The division shall adopt the rules described in this
35 subsection before January 1, 2015. The division shall initiate
36 rulemaking to consider the adoption of any subsequent amendments
37 to the Controlled Therapeutic Medication Schedule adopted by
38 ARCI within 180 days after any such amendments Under no
39 circumstances may any medication be administered closer than 24
40 hours prior to the officially scheduled post time of a race
41 except as provided for in this section.
42 (a) The division shall adopt rules setting conditions for
43 the use of furosemide to treat exercise-induced pulmonary
44 hemorrhage.
45 (b) The division shall adopt rules setting conditions for
46 the use of prednisolone sodium succinate, but under no
47 circumstances may furosemide or prednisolone sodium succinate be
48 administered closer than 4 hours prior to the officially
49 scheduled post time for the race.
50 (c) The division shall adopt rules setting conditions for
51 the use of phenylbutazone and synthetic corticosteroids; in no
52 case, except as provided in paragraph (b), shall these
53 substances be given closer than 24 hours prior to the officially
54 scheduled post time of a race. Oral corticosteroids are
55 prohibited except when prescribed by a licensed veterinarian and
56 reported to the division on forms prescribed by the division.
57 (f)(d) Nothing in this section shall be interpreted to
58 prohibit the use of vitamins, minerals, or naturally occurring
59 substances so long as none exceeds the normal physiological
60 concentration in a race-day specimen.
61 (e) The division may, by rule, establish acceptable levels
62 of permitted medications and shall select the appropriate
63 biological specimens by which the administration of permitted
64 medication is monitored.
65 (8)(a) The only medication authorized to be administered
66 within 24 hours before the officially scheduled post time of a
67 race is furosemide, but under no circumstances may furosemide be
68 administered within 4 hours before the officially scheduled post
69 time of a race.
70 (b) The testing medium for phenylbutazone in horses shall
71 be serum, and the division may collect up to six full 15
72 milliliter blood tubes for each horse being sampled.
73 (8)(a) Under no circumstances may any medication be
74 administered within 24 hours before the officially scheduled
75 post time of the race except as provided in this section.
76 (b) As an exception to this section, if the division first
77 determines that the use of furosemide, phenylbutazone, or
78 prednisolone sodium succinate in horses is in the best interest
79 of racing, the division may adopt rules allowing such use. Any
80 rules allowing the use of furosemide, phenylbutazone, or
81 prednisolone sodium succinate in racing must set the conditions
82 for such use. Under no circumstances may a rule be adopted which
83 allows the administration of furosemide or prednisolone sodium
84 succinate within 4 hours before the officially scheduled post
85 time for the race. Under no circumstances may a rule be adopted
86 which allows the administration of phenylbutazone or any other
87 synthetic corticosteroid within 24 hours before the officially
88 scheduled post time for the race. Any administration of
89 synthetic corticosteroids is limited to parenteral routes. Oral
90 administration of synthetic corticosteroids is expressly
91 prohibited. If this paragraph is unconstitutional, it is
92 severable from the remainder of this section.
93 (c) The division shall, by rule, establish acceptable
94 levels of permitted medications and shall select the appropriate
95 biological specimen by which the administration of permitted
96 medications is monitored.
97 (9)(a) The division may conduct a postmortem examination of
98 any animal that is injured at a permitted racetrack while in
99 training or in competition and that subsequently expires or is
100 destroyed. The division may conduct a postmortem examination of
101 any animal that expires while housed at a permitted racetrack,
102 association compound, or licensed kennel or farm. Trainers and
103 owners shall be requested to comply with this paragraph as a
104 condition of licensure.
105 (b) The division may take possession of the animal upon
106 death for postmortem examination. The division may submit blood,
107 urine, other bodily fluid specimens, or other tissue specimens
108 collected during a postmortem examination for testing by the
109 division laboratory or its designee. Upon completion of the
110 postmortem examination, the carcass must be returned to the
111 owner or disposed of at the owner’s option.
112 (10) The presence of a prohibited substance in an animal,
113 found by the division laboratory in a bodily fluid specimen
114 collected after the race or during the postmortem examination of
115 the animal, which breaks down during a race constitutes a
116 violation of this section.
117 (11) The cost of postmortem examinations, testing, and
118 disposal must be borne by the division.
119 (12) The division shall adopt rules to implement this
120 section. The rules may include a classification system for
121 prohibited substances and a corresponding penalty schedule for
122 violations.
123 (13) Except as specifically modified by statute or by rules
124 of the division, the Uniform Classification Guidelines for
125 Foreign Substances, revised February 14, 1995, as promulgated by
126 the Association of Racing Commissioners International, Inc., is
127 hereby adopted by reference as the uniform classification system
128 for class IV and V medications.
129 (14) The division shall utilize only the thin layer
130 chromatography (TLC) screening process to test for the presence
131 of class IV and V medications in samples taken from racehorses
132 except when thresholds of a class IV or class V medication have
133 been established and are enforced by rule. Once a sample has
134 been identified as suspicious for a class IV or class V
135 medication by the TLC screening process, the sample will be sent
136 for confirmation by and through additional testing methods. All
137 other medications not classified by rule as a class IV or class
138 V agent shall be subject to all forms of testing available to
139 the division.
140 (15) The division may implement by rule medication levels
141 recommended by the University of Florida College of Veterinary
142 Medicine developed pursuant to an agreement between the Division
143 of Pari-mutuel Wagering and the University of Florida College of
144 Veterinary Medicine. The University of Florida College of
145 Veterinary Medicine may provide written notification to the
146 division that it has completed research or review on a
147 particular drug pursuant to the agreement and when the College
148 of Veterinary Medicine has completed a final report of its
149 findings, conclusions, and recommendations to the division.
150 (16) The testing medium for phenylbutazone in horses shall
151 be serum, and the division may collect up to six full 15
152 milliliter blood tubes for each horse being sampled.
153
154 ====== D I R E C T O R Y C L A U S E A M E N D M E N T ======
155 And the directory clause is amended as follows:
156 Delete lines 13 - 14
157 and insert:
158 Section 1. Paragraph (f) is added to subsection (6) of
159 section 550.2415, Florida Statutes, and subsections (7) through
160 (16) of that section are amended, to read:
161
162 ================= T I T L E A M E N D M E N T ================
163 And the title is amended as follows:
164 Delete lines 2 - 8
165 and insert:
166 An act relating to racing animals; amending s.
167 550.2415, F.S.; requiring the Division of Pari-mutuel
168 Wagering within the Department of Business and
169 Professional Regulation to maintain records of
170 greyhounds injured while racing; providing for the
171 content of such records; providing fines for making
172 false statements on an injury form; revising the
173 rulemaking authority of the division; revising the
174 authorized use of certain medications and testing
175 methods; providing an